FDA finalizes guidance on psychedelics, plans broader hearing

July 13, 2026 02:52 PM EDT PharmaFDA+ FDA fi­nal­izes guid­ance on psy­che­delics, plans broad­er hear­ing Max Bayer Senior Reporter The FDA has fi­nal­ized clin­i­cal guid­ance for psy­che­del­ic drug de­vel­op­ers and has sched­uled a pub­lic hear­ing on fu­ture ther­a­peu­tic use, adding reg­u­la­to­ry mo­men­tum to a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER